|
Delayed
London S.E.
16:49:34 01/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.040 GBX | +0.67% |
|
-3.36% | -61.65% |
| 09-22 | EARNINGS and TRADING: Aeorema ups guidance; ZCCM swings to profit | AN |
| 09-22 | SkinBioTherapeutics plc Provides Earnings Guidance for the Fiscal Year 2026 | CI |
| Market Cap | 15.55M 20.64M 18.18M 17.22M 29.31M 1.98B 29.69M 206M 79.31M 1.01B 77.52M 75.83M 3.24B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 19.09M 25.34M 22.32M 21.14M 35.98M 2.43B 36.44M 253M 97.35M 1.24B 95.16M 93.08M 3.98B | EV / Sales 2026 * |
3.08x | EV / Sales 2027 * | 2.33x |
| Free-Float |
58.8% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SBTX | Delayed | |
Deutsche Boerse AG
| 5KW | Delayed | |
|
Börse Stuttgart
| 5KW | Delayed |
Last Transcript: SkinBioTherapeutics plc
| 1 day | +0.67% | ||
| 1 week | -3.36% | ||
| Current month | +0.67% | ||
| 1 month | -36.42% | ||
| 3 months | -42.48% | ||
| 6 months | -37.73% | ||
| Current year | -61.65% |
| 1 week | 5.5 |  | 6.5 |
| 1 month | 5.5 | | 10 |
| Current year | 5 | | 23 |
| 1 year | 5 | | 23 |
| 3 years | 5 | | 29.5 |
| 5 years | 5 | | 78.25 |
| 10 years | 5 | | 88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rachel Parsonage
CEO | Chief Executive Officer | - | 02/03/2026 |
Anita Slater
DFI | Director of Finance/CFO | - | 24/08/2026 |
| Comptroller/Controller/Auditor | - | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/03/2017 | |
Alyson Levett
CHM | Chairman | 60 | - |
Rachel Parsonage
BRD | Director/Board Member | - | 09/03/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/04/23 | Buy | Chief Executive Officer | 122,517 | 0.0708% | ||
| 14/04/23 | Sell | Chief Executive Officer | 123,878 | 0.0715% | ||
| 09/03/23 | Buy | Chief Financial Officer | 86,387 | 0.0499% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.67% | -3.36% | -59.05% | -71.91% | 20.64M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| +1.65% | +2.59% | +29.48% | +83.38% | 60.14B | |
| -1.10% | +0.25% | +6.88% | +35.89% | 48.15B | |
| -0.42% | +0.37% | +41.54% | +36.65% | 44.25B | |
| +2.13% | +7.61% | +339.53% | +641.55% | 43.99B | |
| +1.37% | +0.26% | +7.41% | +103.45% | 41.61B | |
| -0.67% | +0.17% | +7.60% | +46.37% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| +1.70% | -3.55% | -20.74% | +352.04% | 24.93B | |
| Average | +1.13% | +1.81% | +43.88% | +134.44% | 39.68B | |
| Weighted average by Cap. | +1.32% | +1.53% | +59.60% | +148.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.2M 8.23M 7.25M 6.87M 11.69M 789M 11.84M 82.17M 31.62M 403M 30.91M 30.23M 1.29B | 8.2M 10.89M 9.59M 9.08M 15.46M 1.04B 15.66M 109M 41.83M 534M 40.88M 39.99M 1.71B |
| Net income | - | - |
| Net Debt | 3.54M 4.7M 4.14M 3.92M 6.67M 450M 6.75M 46.89M 18.04M 230M 17.64M 17.25M 738M | 3.57M 4.74M 4.17M 3.96M 6.73M 455M 6.82M 47.32M 18.21M 232M 17.8M 17.41M 745M |
Employees
41
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | GBX 6.040 | +0.67% | 176,108 |
| 30/09/26 | GBX 6.000 | 0.00% | 118,475 |
| 29/09/26 | GBX 6.000 | 0.00% | 94,976 |
| 28/09/26 | GBX 6.000 | -4.00% | 491,772 |
| 25/09/26 | GBX 6.250 | 0.00% | 188,412 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0600GBP
Average target price
0.2900GBP
Spread / Average Target
+383.33%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SBTX Stock
Select your edition
All financial news and data tailored to specific country editions
